EFFECTOR THERAPEUTICS INC (EFTR)
US28202V2079 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 8.71M | 49.70M | 15.22M | 3.43M | |||
| Cash Equivalents | 14.88M | N/A | N/A | N/A | N/A | |||
| Marketable Securities | 3.50M | 17.60M | N/A | N/A | N/A | |||
| Other Current Assets | 1.47M | 1.70M | 3.19M | 1.36M | 850.00K | |||
| Total Current Assets | 19.84M | 28.01M | 52.90M | 16.58M | 4.27M | |||
| Non-Current Assets | ||||||||
| PPE Net | 193.00K | 350.00K | 260.00K | 130.00K | 820.00K | |||
| Other Non-Current Assets | 513.00K | 710.00K | 900.00K | 177.94K | N/A | |||
| Total Non-Current Assets | 706.00K | 1.07M | 1.16M | 120.00K | 830.00K | |||
| TOTAL ASSETS | 20.54M | 29.08M | 54.06M | 16.70M | 5.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 19.39M | 19.06M | 0.00 | 5.91M | 14.73M | |||
| Accrued Expenses | 4.08M | 4.07M | 3.11M | 1.74M | 3.16M | |||
| Accounts Payable | 2.33M | 1.49M | 520.00K | 350.00K | 600.00K | |||
| Other Current Liabilities | N/A | 460.00K | 350.00K | 780.00K | 440.00K | |||
| Total Current Liabilities | 25.80M | 25.08M | 3.98M | 8.78M | 18.93M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 18.76M | 6.95M | 0.00 | |||
| Other Non-Current Liabilities | 543.00K | 110.00K | 14.03M | N/A | N/A | |||
| Total Non-Current Liabilities | 543.00K | 100.00K | 32.79M | 6.95M | 0.00 | |||
| TOTAL LIABILITIES | 26.34M | 25.18M | 36.77M | 15.73M | 18.93M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -179.38M | -143.57M | -120.90M | -136.70M | -150.91M | |||
| Additional Paid In Capital | 173.58M | 147.48M | 138.18M | 4.45M | 3.85M | |||
| Common Shares | 300.00 | 0.00 | 0.00 | 133.23M | 133.23M | |||
| Other Shareholders' Equity | -300.00 | -20.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 2.98M | 41.69M | 40.67M | 40.67M | 40.67M | |||
| Tangible Book Value per Share | -1.94 | 0.09 | 0.42 | -3.25 | -3.62 | |||
| Total Shareholders' Equity | -5.79M | 3.90M | 17.28M | 980.00K | -13.84M | |||
| TOTAL LIABILITIES AND EQUITY | 20.54M | 29.08M | 54.06M | 16.70M | 5.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 1.09 | 7.09 | N/A | |||
| Current Ratio | 0.77 | 1.12 | 13.29 | 1.89 | 0.23 | |||
| Return On Assets (ROA) | -174.31% | -77.96% | 29.23% | 1.02% | -278.63% | |||
| Return On Equity (ROE) | N/A | -581.28% | 91.44% | 17.35% | N/A | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 157.80% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 157.80% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 157.80% | N/A | |||
All data in USD